CYC.AX Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 09:10):

Stats
Šios dienos apimtis	1.31M
Vidutinė apimtis	41 155.00
Rinkos kapitalizacija	169.54M
EPS	$0 ( 2024-02-27 )
Last Dividend	$0.00500 ( 2023-09-01 )
Next Dividend	$0 ( N/A )
P/E	-36.00
ATR14	$0 (0.00%)

Cyclopharm Ltd Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Cyclopharm Ltd Finansinės ataskaitos

Annual	2023
Pajamos:	$27.14M
Bruto pelnas:	$4.50M (16.57 %)
EPS:	$-0.0507

FY	2023
Pajamos:	$27.14M
Bruto pelnas:	$4.50M (16.57 %)
EPS:	$-0.0507

FY	2022
Pajamos:	$23.22M
Bruto pelnas:	$5.94M (25.58 %)
EPS:	$-0.0717

FY	2021
Pajamos:	$17.70M
Bruto pelnas:	$12.66M (71.52 %)
EPS:	$-0.0658

Financial Reports:

No articles found.

Cyclopharm Ltd Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.00500 (N/A)	$0 (N/A)	$0.00500 (N/A)	$0 (N/A)	$0.00500 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Cyclopharm Ltd Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.00496	2015-10-02
Last Dividend	$0.00500	2023-09-01
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	17	--
Total Paid Out	$0.0848	--
Avg. Dividend % Per Year	0.00%	--
Score	1.17	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-06-19)

$0.00509 Estimate 7.42 %

Dividend Stability

0.30 Very Poor

Dividend Score

1.17

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for ASX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
TGF.AX	Ex Dividend Junior	2023-09-07	Semi-Annually	0.00%
CUV.AX	Ex Dividend Knight	2023-09-05	Annually	0.00%
NHF.AX	Ex Dividend Knight	2023-09-04	Semi-Annually	0.00%
YAL.AX	Ex Dividend Knight	2023-09-05	Annually	0.00%
FGG.AX	Ex Dividend Junior	2023-10-05	Annually	0.00%
PMV.AX	Ex Dividend Knight	2023-06-20	Semi-Annually	0.00%
ARG.AX	Ex Dividend Knight	2023-08-25	Semi-Annually	0.00%
IFL.AX	Ex Dividend Junior	2023-09-07	Semi-Annually	0.00%
SDG.AX	Ex Dividend Knight	2023-10-24	Quarterly	0.00%
CCP.AX	Ex Dividend Knight	2023-09-18	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.178	1.500	-3.57	-5.35	[0 - 0.5]
returnOnAssetsTTM	-0.102	1.200	-3.41	-4.10	[0 - 0.3]
returnOnEquityTTM	-0.140	1.500	-2.67	-4.00	[0.1 - 1]
payoutRatioTTM	-0.188	-1.000	-1.882	1.882	[0 - 1]
currentRatioTTM	3.48	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	2.26	0.800	1.391	1.113	[0.8 - 2.5]
cashRatioTTM	1.353	1.500	3.60	5.39	[0.2 - 2]
debtRatioTTM	0.0921	-1.500	8.47	-10.00	[0 - 0.6]
interestCoverageTTM	-44.83	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-0.0765	2.00	-0.0255	-0.0510	[0 - 30]
freeCashFlowPerShareTTM	-0.0822	2.00	-0.0411	-0.0822	[0 - 20]
debtEquityRatioTTM	0.131	-1.500	9.48	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.131	1.000	-1.147	-1.147	[0.2 - 0.8]
operatingProfitMarginTTM	-0.368	1.000	-9.35	-9.35	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-1.703	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0.574	0.800	9.51	7.61	[0.5 - 2]
Total Score				-0.485

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-36.03	1.000	-3.74	0	[1 - 100]
returnOnEquityTTM	-0.140	2.50	-1.714	-4.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.0822	2.00	-0.0274	-0.0822	[0 - 30]
dividendYielPercentageTTM	0.278	1.500	3.06	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.0765	2.00	-0.0255	-0.0510	[0 - 30]
payoutRatioTTM	-0.188	1.500	-1.882	1.882	[0 - 1]
pegRatioTTM	0.146	1.500	-2.36	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.273	1.000	-9.33	0	[0.1 - 0.5]
Total Score				-1.924

Cyclopharm Ltd

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. It operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. This segment also distributes third party products to the diagnostic imaging sector. The Molecular Imaging segment provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.